Cromwell Holdings’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.72K Buy
41
+21
+105% +$2.26K ﹤0.01% 709
2026
Q2
$1.74K Buy
20
+9
+82% +$543 ﹤0.01% 874
2026
Q1
$443 Buy
+11
New +$411 ﹤0.01% 989

Other funds holding CORT

Cromwell Holdings's CORT Position: Q3 2026 in Review

Cromwell Holdings increased its Corcept Therapeutics (CORT) stake by 105% in Q3 2026, buying an estimated $2.26K and bringing the position to 41 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #709.

Cromwell Holdings first reported a position in CORT in Q1 2026 and has held it in 3 quarters since. 497 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Cromwell Holdings held 41 shares of Corcept Therapeutics worth $4.72K as of Q3 2026.
  • Cromwell Holdings bought 21 Corcept Therapeutics shares in Q3 2026, an estimated $2.26K.
  • Corcept Therapeutics made up ﹤0.01% of Cromwell Holdings's portfolio in Q3 2026, its #709 holding.
  • Cromwell Holdings first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 497 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.